Erid Labs provides experimental characterization for computational biology, protein engineering, and therapeutics research and development. Its services help discovery teams evaluate candidates, benchmark computational models, and use measured results to guide the next design cycle. The company focuses on making wet lab validation accessible without requiring teams to build their own experimental infrastructure, addressing constraints such as assay setup, laboratory capacity, and manual coordination.

Erid’s current capabilities include target-binding assays and thermal-stability assays. Binding studies characterize interactions between candidates and their targets, helping teams compare designs and support candidate selection. Thermal-stability testing measures how candidates respond to temperature changes and can inform further developability studies. Teams can discuss their target, candidate format, and required readouts with Erid to plan a validation study.

The company’s longer-term vision is a programmable wet lab in which research agents use open-source models to design candidates, request experiments, and incorporate results into subsequent design cycles. Researcher-led validation is available today, while programmatic ordering and autonomous iteration remain future goals.